Recombinant IL9 activation increased the cytotoxicity of tumor-specific mice CD8+ T cells, whereas blocking IL9-signalling decreased the production of granzyme B and perforin in human CD8+ T cells (35). This evidence concerns the gene PRF1 and neoplasm.